ADVANCING CANCER TREATMENT: STEM CELL THERAPIES AND BIOIMAGING INNOVATIONS
Keywords:
Cancer stem cells, Stem cell therapies, Tumor recurrence, Therapy resistanceAbstract
Cancer remains a significant challenge in modern medicine, with cancer stem cells (CSCs) representing a formidable obstacle due to their resistance to conventional therapies and their pivotal role in tumor recurrence. Recent advancements in stem cell therapies offer promising strategies for targeting CSCs and improving treatment efficacy. Moreover, the advent of state-of-the-art bioimaging technologies provides unprecedented insights into the behavior and characteristics of CSCs, facilitating more precise diagnosis and monitoring of therapeutic responses. This paper presents an overview of the latest developments in stem cell-based approaches for cancer treatment and underscores the transformative impact of innovative bioimaging techniques on our understanding of CSC biology. Through an exploration of fertilization, blastocyst formation, and stem cell differentiation potential, as well as an analysis of CSC traits and their interplay with epithelial-mesenchymal transition (EMT), this review illuminates critical pathways in tumor progression and drug discovery. By unraveling the complex dynamics within the tumor microenvironment and elucidating the mechanisms underlying CSC heterogeneity and therapy resistance, this work aims to propel the development of more effective cancer treatment strategies and address existing therapeutic challenges.
References
J. A. Ajani, S. Song, H. S. Hochster, and I. B. Steinberg, "Cancer stem cells: the promise and the potential," in Seminars in oncology, 2015, vol. 42: Elsevier, pp. S3-S17.
M. Shibata and M. O. Hoque, "Targeting cancer stem cells: a strategy for effective eradication of cancer," Cancers, vol. 11, no. 5, p. 732, 2019.
L.-J. Hsu, C.-L. Liu, M.-L. Kuo, C.-N. Shen, and C.-R. Shen, "An alternative cell therapy for cancers: induced pluripotent stem cell (iPSC)-derived natural killer cells," Biomedicines, vol. 9, no. 10, p. 1323, 2021.
R. L. van Ineveld, E. J. van Vliet, E. J. Wehrens, M. Alieva, and A. C. Rios, "3D imaging for driving cancer discovery," The EMBO Journal, vol. 41, no. 10, p. e109675, 2022.
S. Ganesh, K. Venkatakrishnan, and B. Tan, "Quantum scale organic semiconductors for SERS detection of DNA methylation and gene expression," Nature communications, vol. 11, no. 1, p. 1135, 2020.
S. Akbari-Birgani et al., "Cancer stem cells, cancer-initiating cells and methods for their detection," Drug discovery today, vol. 21, no. 5, pp. 836-842, 2016.
J. N. Rich, "Cancer stem cells: understanding tumor hierarchy and heterogeneity," Medicine, vol. 95, no. 1S, pp. S2-S7, 2016.
M. Najafi, K. Mortezaee, and J. Majidpoor, "Cancer stem cell (CSC) resistance drivers," Life sciences, vol. 234, p. 116781, 2019.
D. Nassar and C. Blanpain, "Cancer stem cells: basic concepts and therapeutic implications," Annual Review of Pathology: Mechanisms of Disease, vol. 11, pp. 47-76, 2016.
E. M. De Francesco, F. Sotgia, and M. P. Lisanti, "Cancer stem cells (CSCs): metabolic strategies for their identification and eradication," Biochemical Journal, vol. 475, no. 9, pp. 1611-1634, 2018.
J. Foo et al., "Roadmap on plasticity and epigenetics in cancer," Physical biology, vol. 19, no. 3, p. 031501, 2022.
V. Bitsika, A. Vlahou, and M. G Roubelakis, "Fetal mesenchymal stem cells in cancer therapy," Current stem cell research & therapy, vol. 8, no. 2, pp. 133-143, 2013.
H. Dianat-Moghadam et al., "Cancer stem cells-emanated therapy resistance: implications for liposomal drug delivery systems," Journal of controlled release, vol. 288, pp. 62-83, 2018.
A. Z. Ayob and T. S. Ramasamy, "Cancer stem cells as key drivers of tumour progression," Journal of biomedical science, vol. 25, pp. 1-18, 2018.
Y. Zhao et al., "Targeting cancer stem cells and their niche: perspectives for future therapeutic targets and strategies," in Seminars in cancer biology, 2018, vol. 53: Elsevier, pp. 139-155.
P. K. Raghav and Z. Mann, "Cancer stem cells targets and combined therapies to prevent cancer recurrence," Life sciences, vol. 277, p. 119465, 2021.
R. Kishore and M. Khan, "More than tiny sacks: stem cell exosomes as cell-free modality for cardiac repair," Circulation research, vol. 118, no. 2, pp. 330-343, 2016.
G. Velikic et al., "Harnessing the Stem Cell Niche in Regenerative Medicine: Innovative Avenue to Combat Neurodegenerative Diseases," International Journal of Molecular Sciences, vol. 25, no. 2, p. 993, 2024.
C. Le Guiner et al., "Effective Limb Transduction and Phenotypic Correction after Injection of rAAV8-U7 snRNA in GRMD Dogs," in ASGCT Translational Science Training Course, 2011, vol. 19: Nature Publishing Group, p. 332.
P. S. Kharkar, "Cancer stem cell (CSC) inhibitors in oncology—a promise for a better therapeutic outcome: state of the art and future perspectives," Journal of Medicinal Chemistry, vol. 63, no. 24, pp. 15279-15307, 2020.
K. Chen, C. Zhang, S. Ling, R. Wei, J. Wang, and X. Xu, "The metabolic flexibility of quiescent CSC: Implications for chemotherapy resistance," Cell death & disease, vol. 12, no. 9, p. 835, 2021.
K. Drak Alsibai and D. Meseure, "Tumor microenvironment and noncoding RNAs as co‐drivers of epithelial–mesenchymal transition and cancer metastasis," Developmental Dynamics, vol. 247, no. 3, pp. 405-431, 2018.
J. Massague and K. Ganesh, "Metastasis-initiating cells and ecosystems," Cancer discovery, vol. 11, no. 4, pp. 971-994, 2021.
M. E. Fiori, S. Di Franco, L. Villanova, P. Bianca, G. Stassi, and R. De Maria, "Cancer-associated fibroblasts as abettors of tumor progression at the crossroads of EMT and therapy resistance," Molecular cancer, vol. 18, pp. 1-16, 2019.
X. Zhang et al., "Unraveling the mechanobiology of immune cells," Current Opinion in Biotechnology, vol. 66, pp. 236-245, 2020.
L. G. Marcu, L. Moghaddasi, and E. Bezak, "Imaging of tumor characteristics and molecular pathways with PET: developments over the last decade toward personalized cancer therapy," International Journal of Radiation Oncology* Biology* Physics, vol. 102, no. 4, pp. 1165-1182, 2018.
I. Daimiel, "Insights into hypoxia: non-invasive assessment through imaging modalities and its application in breast cancer," Journal of Breast Cancer, vol. 22, no. 2, p. 155, 2019.
J. Wang and J. V. Jokerst, "Stem cell imaging: tools to improve cell delivery and viability," Stem cells international, vol. 2016, 2016.
Y. N. Ertas, K. Abedi Dorcheh, A. Akbari, and E. Jabbari, "Nanoparticles for targeted drug delivery to cancer stem cells: a review of recent advances," Nanomaterials, vol. 11, no. 7, p. 1755, 2021.
A. J. Studwell and D. N. Kotton, "A shift from cell cultures to creatures: in vivo imaging of small animals in experimental regenerative medicine," Molecular Therapy, vol. 19, no. 11, pp. 1933-1941, 2011.
J. Han et al., "Cancer stem cell-targeted bio-imaging and chemotherapeutic perspective," Chemical Society Reviews, vol. 49, no. 22, pp. 7856-7878, 2020.
G. Thenuwara, B. Javed, B. Singh, and F. Tian, "Biosensor-Enhanced Organ-on-a-Chip Models for Investigating Glioblastoma Tumor Microenvironment Dynamics," Sensors, vol. 24, no. 9, p. 2865, 2024.
Published
Issue
Section
License
Copyright (c) 2024 Journal of Basic Sciences
This work is licensed under a Creative Commons Attribution 4.0 International License.
